DIVERSIFIED PHARMACY, INC. – Trademark Portfolio
Entity Type: 03
DIVERSIFIED PHARMACY, INC. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 5 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include MV, IMPRESSED ADVANTAGE, and MEDIVERA COMPOUNDING PHARMACY. The owner is based in Troy, MI.
6054 Livernois Road
Troy, MI 48098
Showing of trademarks Trademarks
Trademark Classifications
DIVERSIFIED PHARMACY, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does DIVERSIFIED PHARMACY, INC. have?
DIVERSIFIED PHARMACY, INC. has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending, 1 abandoned.
What trademark classes does DIVERSIFIED PHARMACY, INC. file in?
DIVERSIFIED PHARMACY, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.
What are DIVERSIFIED PHARMACY, INC.'s most well-known trademarks?
DIVERSIFIED PHARMACY, INC.'s registered trademark portfolio includes well-known marks such as MV, IMPRESSED ADVANTAGE, and MEDIVERA COMPOUNDING PHARMACY. These are among 3 currently registered trademarks in the portfolio.
What is DIVERSIFIED PHARMACY, INC.'s trademark registration success rate?
DIVERSIFIED PHARMACY, INC. has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 1 application is pending review.